791 related articles for article (PubMed ID: 27917375)
1. Recombinant Lipoprotein Rv1016c Derived from
Su H; Zhu S; Zhu L; Huang W; Wang H; Zhang Z; Xu Y
Front Cell Infect Microbiol; 2016; 6():147. PubMed ID: 27917375
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion.
Pai RK; Convery M; Hamilton TA; Boom WH; Harding CV
J Immunol; 2003 Jul; 171(1):175-84. PubMed ID: 12816996
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis.
Noss EH; Pai RK; Sellati TJ; Radolf JD; Belisle J; Golenbock DT; Boom WH; Harding CV
J Immunol; 2001 Jul; 167(2):910-8. PubMed ID: 11441098
[TBL] [Abstract][Full Text] [Related]
4. Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide.
Tobian AA; Potter NS; Ramachandra L; Pai RK; Convery M; Boom WH; Harding CV
J Immunol; 2003 Aug; 171(3):1413-22. PubMed ID: 12874233
[TBL] [Abstract][Full Text] [Related]
5. Prolonged toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits gamma interferon-induced regulation of selected genes in macrophages.
Pai RK; Pennini ME; Tobian AA; Canaday DH; Boom WH; Harding CV
Infect Immun; 2004 Nov; 72(11):6603-14. PubMed ID: 15501793
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-gamma-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling.
Pennini ME; Pai RK; Schultz DC; Boom WH; Harding CV
J Immunol; 2006 Apr; 176(7):4323-30. PubMed ID: 16547269
[TBL] [Abstract][Full Text] [Related]
7. The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2.
Gehring AJ; Rojas RE; Canaday DH; Lakey DL; Harding CV; Boom WH
Infect Immun; 2003 Aug; 71(8):4487-97. PubMed ID: 12874328
[TBL] [Abstract][Full Text] [Related]
8. LpqT improves mycobacteria survival in macrophages by inhibiting TLR2 mediated inflammatory cytokine expression and cell apoptosis.
Li F; Feng L; Jin C; Wu X; Fan L; Xiong S; Dong Y
Tuberculosis (Edinb); 2018 Jul; 111():57-66. PubMed ID: 30029916
[TBL] [Abstract][Full Text] [Related]
9. ESAT6 differentially inhibits IFN-γ-inducible class II transactivator isoforms in both a TLR2-dependent and -independent manner.
Kumar P; Agarwal R; Siddiqui I; Vora H; Das G; Sharma P
Immunol Cell Biol; 2012 Apr; 90(4):411-20. PubMed ID: 21670739
[TBL] [Abstract][Full Text] [Related]
10. Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms.
Fortune SM; Solache A; Jaeger A; Hill PJ; Belisle JT; Bloom BR; Rubin EJ; Ernst JD
J Immunol; 2004 May; 172(10):6272-80. PubMed ID: 15128816
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function.
Pecora ND; Gehring AJ; Canaday DH; Boom WH; Harding CV
J Immunol; 2006 Jul; 177(1):422-9. PubMed ID: 16785538
[TBL] [Abstract][Full Text] [Related]
12. The Mycobacterium tuberculosis glycoprotein Rv1016c protein inhibits dendritic cell maturation, and impairs Th1 /Th17 responses during mycobacteria infection.
Su H; Peng B; Zhang Z; Liu Z; Zhang Z
Mol Immunol; 2019 May; 109():58-70. PubMed ID: 30856410
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide and KLF4 protein epigenetically modify class II transactivator to repress major histocompatibility complex II expression during Mycobacterium bovis bacillus Calmette-Guerin infection.
Ghorpade DS; Holla S; Sinha AY; Alagesan SK; Balaji KN
J Biol Chem; 2013 Jul; 288(28):20592-606. PubMed ID: 23733190
[TBL] [Abstract][Full Text] [Related]
14. Mycobacterium tuberculosis and Mycobacterium avium inhibit IFN- gamma -induced gene expression by TLR2-dependent and independent pathways.
Lafuse WP; Alvarez GR; Curry HM; Zwilling BS
J Interferon Cytokine Res; 2006 Aug; 26(8):548-61. PubMed ID: 16881865
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing.
Gehring AJ; Dobos KM; Belisle JT; Harding CV; Boom WH
J Immunol; 2004 Aug; 173(4):2660-8. PubMed ID: 15294983
[TBL] [Abstract][Full Text] [Related]
16. Mycobacterium tuberculosis Lipoprotein and Lipoglycan Binding to Toll-Like Receptor 2 Correlates with Agonist Activity and Functional Outcomes.
Shukla S; Richardson ET; Drage MG; Boom WH; Harding CV
Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30037791
[No Abstract] [Full Text] [Related]
17. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses.
Means TK; Jones BW; Schromm AB; Shurtleff BA; Smith JA; Keane J; Golenbock DT; Vogel SN; Fenton MJ
J Immunol; 2001 Mar; 166(6):4074-82. PubMed ID: 11238656
[TBL] [Abstract][Full Text] [Related]
18. Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors.
Harding CV; Boom WH
Nat Rev Microbiol; 2010 Apr; 8(4):296-307. PubMed ID: 20234378
[TBL] [Abstract][Full Text] [Related]
19.
Sengupta S; Naz S; Das I; Ahad A; Padhi A; Naik SK; Ganguli G; Pattanaik KP; Raghav SK; Nandicoori VK; Sonawane A
J Biol Chem; 2017 Apr; 292(17):6855-6868. PubMed ID: 28209712
[No Abstract] [Full Text] [Related]
20. Toll-like receptor 2-dependent extracellular signal-regulated kinase signaling in Mycobacterium tuberculosis-infected macrophages drives anti-inflammatory responses and inhibits Th1 polarization of responding T cells.
Richardson ET; Shukla S; Sweet DR; Wearsch PA; Tsichlis PN; Boom WH; Harding CV
Infect Immun; 2015 Jun; 83(6):2242-54. PubMed ID: 25776754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
